Results from a new study published in Clinical and Translational Immunology found that dual-target antibody therapy can enhance cancer-fighting T cells more effectively than current single-target ...

All drugs require data from various toxicological preclinical studies to support their potential safety in humans before clinical trials can begin. Epigenetic editing of PCSK9 in the liver ...